World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
20800
World Ranking
2393
National Ranking
1147

Overview

Pan Zheng is a researcher affiliated with the University of Maryland, Baltimore in the United States. Their primary fields of study encompass Medicine and Materials Science, with extensive work spanning subfields such as Immunology, Oncology, Biomedical Engineering, Molecular Biology, and Materials Chemistry.

Their research focuses on topics including but not limited to:

  • Nanoplatforms for cancer theranostics
  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Advanced Nanomaterials in Catalysis
  • Immune cells in cancer
  • CAR-T cell therapy research
  • Monoclonal and Polyclonal Antibodies Research

Pan Zheng has contributed to numerous papers published in leading scientific venues. Frequent publication sources include:

  • Angewandte Chemie International Edition
  • Angewandte Chemie
  • Advanced Materials
  • Journal of Clinical Oncology
  • Journal of Applied Polymer Science

Among the recent papers authored or coauthored by Pan Zheng are:

  • "Ultrasound-Augmented Mitochondrial Calcium Ion Overload by Calcium Nanomodulator to Induce Immunogenic Cell Death," published in Nano Letters, 2021
  • "A Multichannel Ca2+ Nanomodulator for Multilevel Mitochondrial Destruction-Mediated Cancer Therapy," published in Advanced Materials, 2021
  • "Manganese Oxide Nanomaterials: Synthesis, Properties, and Theranostic Applications," published in Advanced Materials, 2020
  • "MnOx Nanospikes as Nanoadjuvants and Immunogenic Cell Death Drugs with Enhanced Antitumor Immunity and Antimetastatic Effect," published in Angewandte Chemie International Edition, 2020
  • "ZIF-8 Nanoparticles Evoke Pyroptosis for High-Efficiency Cancer Immunotherapy," published in Angewandte Chemie International Edition, 2023

Their frequent coauthors include Jun Lin, Binbin Ding, Yang Liu, Ping'an Ma, and Jia Tan, indicating a collaborative research approach within their scientific network.

Best Publications

  • Managing toxicities associated with immune checkpoint inhibitors: Consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

    I. Puzanov;A. Diab;K. Abdallah;C. O. Bingham

  • CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses

    Guo-Yun Chen;Jie Tang;Pan Zheng;Yang Liu

  • TSC–mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species

    Chong Chen;Yu Liu;Runhua Liu;Tsuneo Ikenoue

  • mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells

    Chong Chen;Yu Liu;Yang Liu;Pan Zheng

  • FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene

    Tao Zuo;Lizhong Wang;Carl Morrison;Xing Chang

  • Targeting HIF1α eliminates cancer stem cells in hematological malignancies.

    Yin Wang;Yan Liu;Sami N. Malek;Pan Zheng

  • Dendritic cells in the thymus contribute to T-regulatory cell induction

    Anna I. Proietto;Serani van van Dommelen;Penghui Zhou;Alexandra Rizzitelli

  • The Methylcytosine Dioxygenase Tet2 Promotes DNA Demethylation and Activation of Cytokine Gene Expression in T Cells

    Kenji Ichiyama;Tingting Chen;Xiaohu Wang;Xiaowei Yan

  • CD24: from A to Z.

    Xianfeng Fang;Pan Zheng;Jie Tang;Yang Liu

  • FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2

    Tao Zuo;Runhua Liu;Huiming Zhang;Xing Chang

  • Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation.

    Weilin Chen;Chaofeng Han;Bin Xie;Xiang Hu

  • Somatic Single Hits Inactivate the X-Linked Tumor Suppressor FOXP3 in the Prostate

    Lizhong Wang;Runhua Liu;Weiquan Li;Chong Chen

  • T Regulatory Cells and Priming the Suppressive Tumor Microenvironment.

    Christina M. Paluskievicz;Xuefang Cao;Reza Abdi;Pan Zheng

  • A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy

    Xuexiang Du;Fei Tang;Mingyue Liu;Juanjuan Su

  • Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity.

    Ergun Kocak;Kenneth Lute;Xing Chang;Kenneth F. May

  • Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction

    Guo Yun Chen;Xi Chen;Samantha King;Karen A. Cavassani

  • B7DC/PDL2 Promotes Tumor Immunity by a PD-1–independent Mechanism

    Xingluo Liu;Jian Xin Gao;Jing Wen;Lijie Yin

  • Proto-oncogene PML controls genes devoted to MHC class I antigen presentation

    Pan Zheng;Yong Guo;Qingtian Niu;David E. Levy

  • CIITA-regulated plexin-A1 affects T-cell-dendritic cell interactions.

    Athena W. Wong;W. June Brickey;Debra J. Taxman;Hendrick W. van Deventer

  • Spk1, a new kinase from Saccharomyces cerevisiae, phosphorylates proteins on serine, threonine, and tyrosine.

    D F Stern;P Zheng;D R Beidler;C Zerillo

  • CTLA-4–B7 Interaction Is Sufficient to Costimulate T Cell Clonal Expansion

    Yan Wu;Yong Guo;Andy Huang;Pan Zheng

  • Cutting edge: Broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells.

    Guo-Yun Chen;Chong Chen;Lizhong Wang;Xing Chang

  • Erratum to The Methylcytosine Dioxygenase Tet2 Promotes DNA Demethylation and Activation of Cytokine Gene Expression in T Cells (Immunity 42, 613-626, 2015)

    Kenji Ichiyama;Tingting Chen;Xiaohu Wang;Xiaowei Yan

Frequent Co-Authors

Yang Liu
Yang Liu University of Michigan–Ann Arbor
Xue-Feng Bai
Xue-Feng Bai The Ohio State University
Kun-Liang Guan
Kun-Liang Guan Westlake University
Michael A. Caligiuri
Michael A. Caligiuri City Of Hope National Medical Center
Yi Sun
Yi Sun Zhejiang University
Chen Dong
Chen Dong Tsinghua University
Hai Yu
Hai Yu University of California, Davis
Xi Chen
Xi Chen University of California, Davis
Pavan Reddy
Pavan Reddy Baylor College of Medicine
David F. Stern
David F. Stern Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing advanced nursing degrees such as psychiatric mental health nurse practitioner programs can be a strategic move to specialize in immune-related mental health conditions. Exploring the best online psychiatric mental health nurse practitioner programs ensures a combination of quality education and strong clinical experience, vital for career success.

Cost is often a concern when selecting a program. Fortunately, there are affordable options available, and researching the cheapest psychiatric nurse practitioner programs can help prospective students find budget-friendly pathways without compromising educational standards.

Understanding the financial rewards of advanced degrees is just as important. Transparency in earnings is becoming more common, and resources detailing the dnp salary transparency offer insights into regional salary variations for Doctor of Nursing Practice graduates, aiding informed career decisions.

For nursing professionals, transitional pathways such as the move from family nurse practitioner to more intensive roles like acute care nurse practitioner offer growth opportunities. Learning how to make the transition effectively is essential, and guides on fnp to acnp transitions provide valuable steps and considerations.

Best Scientists Citing Pan Zheng

Trending Scientists